Israel’s LabStyle Innovations, the maker of the Dario smart meter for diabetics, announced that it has been granted reimbursement status for its Dario blood glucose test strips to be utilized together with the patented Dario smart meter in Australia.
Dario is a cloud-based, diabetes management solution which includes software applications combined with the patented Dario smart meter which interfaces with a user’s mobile device to form the overall Dario Diabetes Management Solution.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Through the Pharmaceutical Benefits Scheme (PBS) people with diabetes in Australia will now be entitled to be subsidized for Dario™ smart meter test strips which will be made available at all pharmacies in Australia. According to the International Diabetes Federation (IDF) there were 1.6 million cases of Diabetes in Australia in 2013 and for every person diagnosed, it is estimated that there is another person who is not yet diagnosed. In Australia 2.3% of all health expenditure is spent on treating diabetes.
Dario™ is marketed and distributed by uHealth Australia Pty Limited (uHealth) in Australia, a leading distributor of digital health and surgical innovations.
“We are delighted with the market demand that has been demonstrated in the initial territories where we have marketed the Dario smart meter and we have been working very hard to ensure customer supply and satisfaction. We believe our promising results are due to the very positive experiences encountered by the Dario community along with their actual evidenced improvement in performance when using Dario. We are proud to be able to bring this cutting edge diabetes management platform to the large population of insulin dependent people in Australia now. By making Dario available through the Pharmaceutical Benefits Scheme more diabetic adults, children and their concerned families will be empowered with Dario™ to improve their quality of life”, commented Erez Raphael, LabStyle Innovations president and chief executive officer.
“This is wonderful news for the large population of people with diabetes in Australia and is a major milestone for us in that the Pharmaceutical Benefits Advisory Committee has recognized the Dario™ smart meter for its contribution to the well-being of diabetics in Australia” said Mr. Will Knox, Director of uHealth. “By making Dario™ available through reimbursement, more people with diabetes will be able to make better informed decisions and improve their lifestyle and we expect expansive demand for the product here in Australia.”
